BLFS vs STAA: fair value comparison
BioLife Solutions, Inc. and STAAR Surgical Company · Updated 2026-10-19
BLFS's estimate rests on a sector-average multiple, which TickrTrends does not publish as a verdict. Within Healthcare, BLFS currently ranks higher by quality score.
| BLFS | STAA | |
|---|---|---|
| Verdict | Awaiting full valuation | Undervalued |
| Last price | $38.61 | $21.27 |
| 12-month range | $18.15–$39.22 | $16.10–$33.34 |
| Rank by discount to fair value | — | #3 of 108 Healthcare |
| Rank by quality score | #111 of 301 Healthcare | #112 of 301 Healthcare |
| Quality grade | C | C |
| Leverage | Low | Low |
| Margin trend | Contracting | Expanding |
| Revenue growth | Modest | Modest |
| RSI zone | Neutral | Neutral |
| 50/200-day trend | Uptrend | Downtrend |
| 52-week position | The top quarter | The lower-middle quarter |
Full single-stock breakdowns: BLFS fair value analysis · STAA fair value analysis